MVP 1.11% 45.5¢ medical developments international limited

Ann: MVP Announces $10M Capital Raise, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 851 Posts.
    lightbulb Created with Sketch. 251
    Yes I wonder about that too. At least I was a little uncertain as to how they costed their result and how much the self administered element came into the mix. I'm just relaying what I read.

    The underlying issue here is that success, I think, is linked to the ability of the marketing teams to introduce Penthrox into hospital emergency departments
    and short surgical procedures where costs are an urgent issue right now.
    There hasn't been any measurable success here and my thoughts are that costs may be a stumbling block.

    The thrust of this discussion is whether or not the business model can't be made to work, or it can be made to work but management's just not very good at it.
    Because I don't have any connection to the industry, I'm not sure I know the answers, but I think they're the questions.
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
45.5¢
Change
0.005(1.11%)
Mkt cap ! $51.25M
Open High Low Value Volume
45.0¢ 46.0¢ 44.0¢ $19.9K 44.88K

Buyers (Bids)

No. Vol. Price($)
1 44643 44.5¢
 

Sellers (Offers)

Price($) Vol. No.
46.0¢ 2000 1
View Market Depth
Last trade - 15.57pm 08/11/2024 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.